Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2

Molecular and Cellular Neuroscience

Volumn 16, Issue 6, 2000, Pages 724-739

  Knott, C ^a   Stern, G ^b   Wilkin, G P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FERROUS SULFATE; FLUOXETINE; LEVODOPA; LIPOCORTIN 1; NITRIC OXIDE SYNTHASE; PERGOLIDE; PROSTAGLANDIN; SELEGILINE; SULPIRIDE; THIORIDAZINE;

AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SUBSTANTIA NIGRA;

EID: 0034520395     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0914     Document Type: Article

References (118)

1. High potassium enhances secretion of neurotrophic factors from cultured astrocytes
2. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
3. Feedback inhibition of nitric oxide synthase activity by nitric oxide
4. Activation of inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
5. Cytotoxicity of microglia
6. The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity
7. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
8. Energetics in the pathogenesis of neurodegenerative diseases
9. Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
10. GDNF protects mesencephalic dopaminergic neurons from axotomy-induced degeneration in the adult brain
11. Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of rat
12. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
13. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
14. Pattern of brain destruction in Parkinson's and Alzheimer's diseases
15. Characterization of inducible cyclooxygenase in rat brain
16. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production
17. Lipocortin-1 modifies the pyrogenic actions of cytokines in the rat
18. Protection by prostaglandins from glutamate toxicity in cortical neurons
19. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
20. Molecular cloning, structure and chromosomal localisation of the human inducible nitric oxide synthase gene
21. Glutathione peroxidase, glial cells and Parkinson's disease
22. Antipyretic actions of human recombinant lipocortin-1
23. A novel neuronal messenger molecule in brain: The free radical, nitric oxide
24. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
25. Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices
26. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids
27. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
28. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo
29. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin synthase-2 isozymes
30. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease
31. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide
32. Oxidative stress and antioxidant therapy in Parkinson's disease
33. Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis
34. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function
35. Lipocortin and the mechanism of action of the glucocorticoids
36. Lipocortin-1: Cellular mechanisms and clinical relevance
37. Neuropathology of Parkinson's disease
38. Astrocytes and Parkinson's disease
39. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetlycholine
40. Glutamate, nitric oxide and cell-cell signalling in the nervous system
41. Reactive microglia in cerebral ischaemia: An early mediator of tissue damage?
42. Reactive mononuclear phagocytes release neurotoxins after ischaemic and traumatic injury to the central nervous system
43. Interleukin-1 stimulation of astroglial proliferation after brain injury
44. Inflammatory signals induce neurotrophin expression in human microglial cells
45. Prostaglandin synthase 2
46. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease
47. Expression of Cox-2 by normal and reactive astrocytes in the adult rat brain central nervous system
48. Tumor necrosis factor identified in multiple sclerosis brain
49. Transient induction of neuronal nitric oxide synthase in neurons of rat cerebra/cortex after status epilepticus
50. Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat
51. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
52. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease
53. Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum
54. Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment
55. Oxidative damage in neurodegenerative disease
56. Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease
57. Characterisation of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2
58. Neuroimmune mechanisms in Parkinson's disease
59. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis
60. Long-term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain
61. Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 invloves the p42/44 and p38 MAPK signalling pathways in cardiac myocytes
62. Cytokine production by human fetal microglia and astrocytes
63. Nitric oxide synthase immunoreactivity in the rat hippocampus after status epilepticus induced by perforant pathway stimulation
64. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
65. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus
66. Microglial cell cytotoxicity of oligodendrocytes is mediated via nitric oxide
67. In vivo study of mediators of inflammation in multiple sclerosis
68. Expression of both constitutive and inducible nitric oxide synthases in neuronal and astrocyte cultures
69. Restricted cyclo-oxygenase-2 expression in the central nervous system following acute and delayed-type hypersensitivity responses to bacillus calmette-guerin
70. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors
71. Down-regulation of microglial cyclo-oxygenase-2 inducible nitric oxide synthase expression by lipocortin-1
72. Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression
73. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from Parkinson's patients
74. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
75. Nitric oxide: Physiology, pathology and pharmacology
76. Up-regulation of lipocortin-1 and its mRNA in reactive astrocytes in kainate-lesioned rat cerebellum
77. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
78. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
79. Glial NO: Normal and pathological roles
80. Synthesis of nitric oxide in CNS glial cells
81. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain
82. Transcriptional induction of endothelial nitric oxide gene by cyclosporin A: A role for activator protein-1
83. Cycooxygenase-2 gene expression in neurons contributes to ischemic brain damage
84. Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support
85. Local support cells promote survival of substantia nigra dopaminergic neurons in culture
86. The type I astrocyte subtype augments substantia nigra dopaminergic neuron survival
87. Nitric oxide in acute ischemic stroke: A target for neuroprotection
88. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
89. 1 induces c-fos and myc proteins and protects rat hippocampal cells against hypoxic injury
90. Nitric oxide limits transcriptional induction of nitric oxide synthase in glial cells
91. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA
92. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
93. Glucocorticolds modulate the cellular disposition of lipocortin-1 in the rat brain in vivo and in vitro
94. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid binding proteins
95. Lipocorfind is an endogenous inhibitor of ischemic damage in the rat brain
96. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage
97. Nitric oxide activates cyclooxygenase enzymes
98. Nitric oxide synthase in models of focal ischemia
99. 2 and cyclooxygenase-2 in the hippocampus after kainate lesions
100. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
101. Anatomic and disease specificity of NADH CoQ1 reductase (complex 1) deficiency in Parkinson's disease
102. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
103. Prostaglandin endoperoxide H synthases-1 and -2
104. Studies on the induction of lipocortin-1 by glucocorticoids
105. Tumor necrosis factor modulates Ca2+ currents in cultured sympathetic neurons
106. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF
107. Localization of immunoreactive lipocortin-1 in the brain and pituitary gland of the rat: Effects of adrenalectomy, dexamethasone and colchicine treatment
108. The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells
109. Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration
110. Reactive microglia express class I and Class II major histocompatibility complex antigens in Alzheimer's disease
111. Divergent effects of astroglial and microglial secretions on neuron growth and survival
112. Inducible nitric oxide synthase intangle-bearing neurons of patients with Alzheimer's disease
113. Glia: A curtain raiser
114. Biochemical responses of astrocytes to neuroactive peptides
115. Prostaglandin endoperoxide synthase: Why two isoforms?
116. Protective effect of KBT-3022, a new cyclo-oxygenase inhibitor, in cerebral hypoxia and ischemia
117. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
118. De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum